TONIX PHARMACEUTICALS HOLDING CORP. Increase Decrease In Operating Lease Liability
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Increase Decrease In Operating Lease Liability of $160.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-10
- TONIX PHARMACEUTICALS HOLDING CORP. increase decrease in operating lease liability for the quarter ending 2026-06-30 was $80.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. increase decrease in operating lease liability for the quarter ending 2026-03-31 was $80.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$285.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$6.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. increase decrease in operating lease liability for fiscal 2025 was -$303.00K.
- TONIX PHARMACEUTICALS HOLDING CORP. increase decrease in operating lease liability for fiscal 2024 was -$13.00K, a 137.14% decline from fiscal 2023.
- TONIX PHARMACEUTICALS HOLDING CORP. increase decrease in operating lease liability for fiscal 2023 was $35.00K, a 1650.00% increase from fiscal 2022.
- TONIX PHARMACEUTICALS HOLDING CORP. increase decrease in operating lease liability for fiscal 2022 was $2.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $160.00K 10-Q · filed 2026-08-10 | -$125.00K derived: sum of 3 quarters · filed 2026-08-10 | -$131.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $80.00K 10-Q · filed 2026-05-11 | -$205.00K derived: sum of 2 quarters · filed 2026-05-11 | -$211.00K derived: sum of 3 quarters · filed 2026-05-11 | -$218.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$285.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$291.00K derived: sum of 2 quarters · filed 2026-03-12 | -$298.00K derived: sum of 3 quarters · filed 2026-08-10 | -$303.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$13.00K derived: sum of 2 quarters · filed 2026-08-10 | -$18.00K 10-Q · filed 2025-11-10 | -$23.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$12.00K 10-Q · filed 2026-08-10 | -$17.00K derived: sum of 3 quarters · filed 2026-08-10 | -$23.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$5.00K 10-Q · filed 2026-05-11 | -$10.00K derived: sum of 2 quarters · filed 2026-05-11 | -$16.00K derived: sum of 3 quarters · filed 2026-05-11 | -$20.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$11.00K derived: sum of 2 quarters · filed 2026-03-12 | -$15.00K derived: sum of 3 quarters · filed 2026-03-12 | -$13.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$10.00K derived: sum of 2 quarters · filed 2025-11-10 | -$8.00K 10-Q · filed 2025-11-10 | $3.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$2.00K 10-Q · filed 2025-08-11 | $9.00K derived: sum of 3 quarters · filed 2025-08-11 | $26.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $2.00K 10-Q · filed 2025-05-12 | $13.00K derived: sum of 2 quarters · filed 2025-05-12 | $30.00K derived: sum of 3 quarters · filed 2025-05-12 | $42.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $28.00K derived: sum of 2 quarters · filed 2025-03-18 | $40.00K derived: sum of 3 quarters · filed 2025-03-18 | $35.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $29.00K derived: sum of 2 quarters · filed 2024-11-12 | $24.00K 10-Q · filed 2024-11-12 | $21.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-16 | $7.00K 10-Q · filed 2024-08-16 | $4.00K derived: sum of 3 quarters · filed 2024-08-16 | $7.00K derived: sum of 4 quarters · filed 2024-08-16 |
| 2023-03-31 | -$5.00K 10-Q · filed 2024-05-13 | -$8.00K derived: sum of 2 quarters · filed 2024-05-13 | -$5.00K derived: sum of 3 quarters · filed 2024-05-13 | -$2.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $3.00K derived: sum of 3 quarters · filed 2024-04-01 | $2.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $6.00K derived: sum of 2 quarters · filed 2023-11-09 | $5.00K 10-Q · filed 2023-11-09 | $4.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.00K 10-Q · filed 2023-08-10 | $1.00K derived: sum of 3 quarters · filed 2023-08-10 | $8.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$1.00K 10-Q · filed 2023-05-08 | -$2.00K derived: sum of 2 quarters · filed 2023-05-08 | $5.00K derived: sum of 3 quarters · filed 2023-05-08 | $0.00 derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $6.00K derived: sum of 2 quarters · filed 2023-03-13 | $1.00K derived: sum of 3 quarters · filed 2023-03-13 | -$11.00K 10-K · filed 2023-03-13 |
| 2021-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $2.00K derived: sum of 2 quarters · filed 2022-11-07 | -$10.00K 10-Q · filed 2022-11-07 | $33.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$17.00K 10-Q · filed 2022-08-08 | $26.00K derived: sum of 3 quarters · filed 2022-08-08 | |
| 2021-03-31 | -$12.00K 10-Q · filed 2022-05-09 | $31.00K derived: sum of 2 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $51.00K 10-K · filed 2022-03-14 | ||
| 2020-09-30 | $8.00K 10-Q · filed 2021-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |